ATE465179T1 - Antikörper, antikörperfragmente und scfv die an posttranslational modifizierte neurotrophine binden - Google Patents
Antikörper, antikörperfragmente und scfv die an posttranslational modifizierte neurotrophine bindenInfo
- Publication number
- ATE465179T1 ATE465179T1 AT06291195T AT06291195T ATE465179T1 AT E465179 T1 ATE465179 T1 AT E465179T1 AT 06291195 T AT06291195 T AT 06291195T AT 06291195 T AT06291195 T AT 06291195T AT E465179 T1 ATE465179 T1 AT E465179T1
- Authority
- AT
- Austria
- Prior art keywords
- scfv
- antibodies
- bind
- post
- antibody fragments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06291195A EP1882697B1 (de) | 2006-07-24 | 2006-07-24 | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE465179T1 true ATE465179T1 (de) | 2010-05-15 |
Family
ID=37075006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06291195T ATE465179T1 (de) | 2006-07-24 | 2006-07-24 | Antikörper, antikörperfragmente und scfv die an posttranslational modifizierte neurotrophine binden |
Country Status (11)
Country | Link |
---|---|
US (2) | US20100055109A1 (de) |
EP (2) | EP1882697B1 (de) |
JP (1) | JP5528803B2 (de) |
AR (1) | AR062038A1 (de) |
AT (1) | ATE465179T1 (de) |
BR (1) | BRPI0714545A2 (de) |
CA (1) | CA2657563A1 (de) |
DE (1) | DE602006013809D1 (de) |
HK (1) | HK1116806A1 (de) |
UY (1) | UY30501A1 (de) |
WO (1) | WO2008012049A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1882697B1 (de) * | 2006-07-24 | 2010-04-21 | Institut Pasteur | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
US20120135973A1 (en) * | 2010-09-08 | 2012-05-31 | Southern Illinois University Edwardsville | Method for treating chronic pain |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
AU2011336470B8 (en) | 2010-12-01 | 2017-09-14 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
US20180236031A1 (en) * | 2017-02-10 | 2018-08-23 | Vivibaba, Inc | Compositions and methods for recombinant nerve growth factor |
EP3775202A4 (de) * | 2018-03-27 | 2022-04-06 | Factor Bioscience Inc. | Auf nukleinsäure basierende therapeutika |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
AU701342B2 (en) | 1994-07-13 | 1999-01-28 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin-8 |
US6068040A (en) | 1998-07-24 | 2000-05-30 | Alpine Overhead Doors, Inc. | Slat edge retainer for overhead rolling doors |
EP1500399A1 (de) | 2003-07-24 | 2005-01-26 | Institut Pasteur | Aktive und passive Immunisierung gegen pro-apoptotischen Neurotrophinen zur Behandlung oder Vorbeugung von neurologischen Krankheiten |
EP1882697B1 (de) * | 2006-07-24 | 2010-04-21 | Institut Pasteur | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
-
2006
- 2006-07-24 EP EP06291195A patent/EP1882697B1/de not_active Not-in-force
- 2006-07-24 DE DE602006013809T patent/DE602006013809D1/de active Active
- 2006-07-24 AT AT06291195T patent/ATE465179T1/de not_active IP Right Cessation
-
2007
- 2007-07-23 WO PCT/EP2007/006528 patent/WO2008012049A1/en active Application Filing
- 2007-07-23 CA CA002657563A patent/CA2657563A1/en not_active Abandoned
- 2007-07-23 JP JP2009521157A patent/JP5528803B2/ja not_active Expired - Fee Related
- 2007-07-23 US US12/374,485 patent/US20100055109A1/en not_active Abandoned
- 2007-07-23 EP EP07786268A patent/EP2046823B1/de not_active Not-in-force
- 2007-07-23 BR BRPI0714545-4A patent/BRPI0714545A2/pt not_active IP Right Cessation
- 2007-07-24 AR ARP070103275A patent/AR062038A1/es unknown
- 2007-07-24 UY UY30501A patent/UY30501A1/es not_active Application Discontinuation
-
2008
- 2008-07-08 HK HK08107507.3A patent/HK1116806A1/xx not_active IP Right Cessation
-
2013
- 2013-09-26 US US14/037,973 patent/US9328163B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100055109A1 (en) | 2010-03-04 |
JP2010501475A (ja) | 2010-01-21 |
CA2657563A1 (en) | 2008-01-31 |
AR062038A1 (es) | 2008-08-10 |
DE602006013809D1 (de) | 2010-06-02 |
US20140178384A1 (en) | 2014-06-26 |
UY30501A1 (es) | 2009-04-30 |
EP1882697A1 (de) | 2008-01-30 |
WO2008012049A1 (en) | 2008-01-31 |
EP2046823A1 (de) | 2009-04-15 |
BRPI0714545A2 (pt) | 2013-05-14 |
EP1882697B1 (de) | 2010-04-21 |
HK1116806A1 (en) | 2009-01-02 |
US9328163B2 (en) | 2016-05-03 |
JP5528803B2 (ja) | 2014-06-25 |
EP2046823B1 (de) | 2012-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE465179T1 (de) | Antikörper, antikörperfragmente und scfv die an posttranslational modifizierte neurotrophine binden | |
HRP20190312T1 (hr) | Vežući proteini, uključujući protutijela, derivate protutijela i fragmente protutijela, koji se specifično vežu na cd154 i njihova upotreba | |
BRPI0822447A2 (pt) | Anticorpo monoclonal e método do mesmo | |
EP2322562A4 (de) | Monoklonaler antikörper und immunassay damit | |
IL197928A (en) | A monoclonal antibody munched on steap-1, its immunoconjugates its uses | |
IL202232A0 (en) | Novel rabbit antibody humanization methods and humanized rabbit antibodies | |
SI2510011T1 (sl) | Monoklonska protitelesa, ki veĹľejo B7H6 in njihova uporaba | |
ZA201003496B (en) | Monoclonal antibody capable of binding to anexelekto,and use thereof | |
IL211742A (en) | Isolated monoclonal antibodies specifically associated with frizzled receptor and various aspects thereof | |
BRPI0818780A2 (pt) | Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos | |
IL198592A0 (en) | Tes7 and antibodies that bind thereto | |
ZA200809662B (en) | Modified humanised anti-interleukin-18 antibodies | |
EP2021373A4 (de) | Vcam-1-spezifischer monoklonaler antikörper | |
FI20070853A0 (fi) | Glykaania sitovat monoklonaaliset vasta-aineet | |
FI20075278A0 (fi) | Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet | |
IL196550A0 (en) | Anti-il-6 monoclonal antibodies and uses thereof | |
BRPI0916915A2 (pt) | anticorpos anti-il-17a/f de reatividade cruzada e biespecíficos | |
BRPI0918178A2 (pt) | anticorpos monoclonais para tratamento de câncer | |
BRPI1005176A2 (pt) | ensaio de insulina, reagente de ensaio de insulina, anticorpo monoclonal, e, método de triar anticorpos monoclonais. | |
EP2233503A4 (de) | Monoklonale anti-ofloxacin-antikörper und immunassayverfahren auf ofloxacin unter anwendung davon | |
IL220622A0 (en) | Monoclonal antibodies against activated and unactivated protein c | |
BR112012025082A2 (pt) | novos anticorpos monoclonais e método de análise imunológica de dímero-d | |
DK2094728T3 (da) | Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer | |
EP2292659A4 (de) | Monoklonaler antikörper gegen das schweiss-antigen | |
HK1158977A1 (zh) | 抗膜鐵轉運蛋白 單克隆抗體及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |